Helix BioPharma Corp. (HBP) — Long-term Investment Intensity
Helix BioPharma Corp. (HBP) has a Long-term Investment Intensity of 2.8% as of July 2011. Long-term investments of CA$692.00K represent 2.8% of total assets of CA$24.37 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore cash efficiency ratio of Helix BioPharma Corp. to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Helix BioPharma Corp. Long-term Investment Intensity (2009–2011)
This chart shows how Helix BioPharma Corp.'s Long-term Investment Intensity has evolved across 3 annual periods from 2009 to 2011. As of July 2011, the intensity stands at 2.8%, reflecting long-term investments of CA$692.00K against total assets of CA$24.37 Million CAD. Explore HBP operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Helix BioPharma Corp. (2009–2011)
The table below presents the year-by-year Long-term Investment Intensity for Helix BioPharma Corp. from 2009 to 2011, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see HBP market cap overview.
| Year | LT Investment Intensity | LT Investments (CAD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2011 | 2.8% | CA$692.00K | CA$24.37 Million | ▲ +0.4 pp |
| 2010 | 2.5% | CA$446.00K | CA$18.11 Million | ▲ +2.2 pp |
| 2009 | 0.3% | CA$56.00K | CA$19.32 Million | — |